Expansion of production capacity and capabilities for new materials through the new building at the Konosu Research Institute
First written in FY2016. 27 of 36 entries say "Advanced", first in FY2017-Q1. Latest entry: 2026-08-25.
No other company in this theme has enough history to compare yet.
- FY2026AdvancedAnnual report
「Building 4, completed in January 2026, began operations in March.」
Completion of Building 4 at the Konosu Research Institute and the start of operations in March 2026 were reported, marking progress from the previous construction and preparation stage to the operating stage. - FY2026-H1RaisedAnnual report
「Preparation is also under way for the second-phase construction of Building 4. Once the plan is completed, production capacity is expected to increase to a maximum of 89.5 million sheets per month, or 1.074 billion sheets per year.」
The production capacity plan was increased from the previous estimate of 89 million sheets per month upon completion of the second phase of Building 4 to 89.5 million sheets per month and 1.074 billion sheets per year. - FY2025AdvancedAnnual report
「At the Konosu Research Institute, we are working to substantially increase production capacity in order to establish a presence in the contact lens market, where demand is expected to continue expanding in Japan and overseas. Following the annex to Building 2, which has commenced full-scale operations, construction of Building 4 began in November 2024. The plan for Building 4 targets completion of the building in January 2026 and the start of production in March 2026 under the first-phase plan.」
The annex to Building 2 commenced full-scale operations, and construction of Building 4 began in November 2024. Completion of the building is targeted for January 2026, with first-phase production scheduled to begin in March 2026. - FY2025-H1RaisedAnnual report
「Maximum monthly production was 58 million sheets at the end of the fiscal year ending March 2024. Following completion of the newly constructed annex to Building 2 in April 2024, manufacturing equipment was installed in stages, and installation of all machinery was completed in early October 2024. As a result, maximum monthly production will increase to 65 million sheets from the third quarter onward.」
The annex to Building 2 was completed in April 2024, and installation of all machinery was completed in early October 2024, advancing the increase in maximum monthly production from 58 million sheets to 65 million sheets. The scale of increased production and investment for Building 4 was also expanded. - FY2024-Q3RaisedAnnual report
「At a meeting of the Board of Directors held on 7 February 2024, the Company resolved to construct a contact lens manufacturing plant, Building 4 of the Konosu Research Institute, and install manufacturing equipment.」
Following renewal of existing buildings, expansion of production lines and construction of the annex, construction of Building 4 was approved. The investment amount is ¥13.1 billion, planned post-completion capacity is 10 million sheets per month, and construction was scheduled to begin in August 2024 with completion scheduled for January 2026, further increasing the production capacity expansion plan. - FY2024-Q2RaisedAnnual report
「At the Konosu Research Institute, we are advancing a plan to increase maximum planned monthly production from the current 53 million sheets to 58 million sheets in the fiscal year ending March 2024 through renewal of aging production equipment in Building 1 and a new expansion of the Building 3 line, and from 58 million sheets to 65 million sheets in the fiscal year ending March 2025 through construction of the annex to Building 2.」
Regarding the production capacity plan for the Konosu Research Institute, maximum planned monthly production after construction of the annex to Building 2 was increased from the previous 64 million sheets to 65 million sheets. The phased plan of renewing equipment in Building 1, expanding the Building 3 line and constructing the annex to Building 2 also continues. - FY2024-Q1AdvancedAnnual report
「The Group plans to increase production capacity at the Konosu Research Institute, its main production base, including by adding production equipment. For the fiscal year ending March 2024, it plans to raise maximum planned monthly production from the current 53 million lenses to 58 million through the renewal of aging production equipment in Building 1 and the addition of a new line in Building 3. For the fiscal year ending March 2025, it plans to raise this from 58 million to 64 million lenses through the extension of Building 2 and construction of an annex.」
The existing plans for expansion of the Building 3 line and construction of the annex to Building 2 were developed into a phased production capacity plan including equipment renewal in Building 1, with targets set for maximum planned monthly production. - FY2023AdvancedAnnual report
「For contact lens manufacturing equipment, including the expansion of the Building 3 line, an increase in capacity of 9% after completion was planned from April 2023 to December 2023. For construction of the contact lens manufacturing plant, namely the annex to Building 2, an increase in capacity of 10% after completion was planned from July 2023 to April 2024.」
At the Konosu Research Institute, expansion of the Building 3 line and construction and equipment installation for the annex to Building 2 were planned, with post-completion production capacity expected to increase by 9% and 10%, respectively. - FY2023-Q2AdvancedAnnual report
「This was mainly attributable to expenditure of ¥650 million for the acquisition of property, plant and equipment associated with the installation of equipment and other activities at the Konosu Research Institute to increase production of Seed 1daySilfa (Silfa).」
Equipment for increasing Silfa production was installed at the Konosu Research Institute, resulting in the acquisition of ¥650 million in property, plant and equipment. - FY2022AdvancedAnnual report
「This was attributable to expenditure of ¥1,097 million for the acquisition of property, plant and equipment associated with expansion work on the production area and the installation of equipment and other activities at the Konosu Research Institute.」
¥1,097 million was spent on expansion work on the production area and the installation of equipment at the Konosu Research Institute, and development of the production base continued. - FY2022-Q3AdvancedAnnual report
「Cash used in investing activities was ¥562 million (an outflow of ¥1,948 million in the same period of the previous year). The main factors were ¥410 million in expenditure on the acquisition of shares in 株式会社ユニバーサルビュー and ¥838 million in expenditure on the acquisition of property, plant and equipment associated with the expansion of the manufacturing area and installation of equipment at the Konosu Research Institute.」
¥838 million was spent on expansion work on the production area and the installation of equipment at the Konosu Research Institute, and equipment development toward expanding production capacity continues. - FY2022-Q2AdvancedAnnual report
「Cash used in investing activities was ¥703 million (an outflow of ¥1,638 million in the same period of the previous year). The main factors were ¥410 million in expenditure on the acquisition of shares in 株式会社ユニバーサルビュー and ¥692 million in expenditure on the acquisition of property, plant and equipment associated with the expansion of the manufacturing area and installation of equipment at the Konosu Research Institute.」
¥692 million was spent on expansion work on the production area and the installation of equipment at the Konosu Research Institute, advancing the expansion of the production base. - FY2022-Q1AdvancedAnnual report
「Expenditure of ¥292 million for the acquisition of property, plant and equipment associated with expansion work on the production area and the installation of equipment and other activities at the Konosu Research Institute.」
Expansion work on the production area and the installation of equipment at the Konosu Research Institute continued, with ¥292 million invested in capital expenditures. - FY2021-Q3AdvancedAnnual report
「Assets at the end of the third quarter of the current consolidated fiscal year stood at ¥43,801 million, an increase of ¥2,209 million from the end of the previous consolidated fiscal year. The main factor was an increase in property, plant and equipment associated with completion of the product warehouse building and the installation of equipment at the Konosu Research Institute.」
Completion of the product warehouse building and progress with equipment installation at the Konosu Research Institute were cited as factors behind the increase in assets. - FY2021-Q1AdvancedAnnual report
「Assets at the end of the first quarter of the current consolidated fiscal year stood at ¥43,270 million, an increase of ¥1,683 million from the end of the previous consolidated fiscal year. The main factors included an increase in property, plant and equipment associated with completion of the product warehouse building and the installation of equipment at the Konosu Research Institute.」
The product warehouse building at the Konosu Research Institute was completed, and equipment installation also progressed. Expansion of the production and supply base through the new building and equipment development made concrete progress. - FY2020AdvancedAnnual report
「The total amount of capital expenditures made by the Group during the current consolidated fiscal year was ¥3,317 million. The main expenditures were for expansion work on Building 3 at the Konosu Research Institute and the installation of manufacturing equipment for the contact lens and lens-care products business.」
Expansion work and the installation of manufacturing equipment were carried out at Building 3 of the Konosu Research Institute, representing concrete progress with total capital expenditures of ¥3,317 million. - FY2020-Q3AdvancedAnnual report
「The main factor was an increase in property, plant and equipment associated with the expansion of the production area and installation of equipment in Building 3 at the Konosu Research Institute.」
The expansion of the production area and installation of equipment in Building 3 at the Konosu Research Institute continued. Investing activities included the acquisition of ¥1,994 million in property, plant and equipment, including assets related to the institute. - FY2020-Q2AdvancedAnnual report
「Assets at the end of the second quarter of the current consolidated fiscal year stood at ¥41,578 million, an increase of ¥1,632 million from the end of the previous consolidated fiscal year. The main factors included an increase in property, plant and equipment associated with the expansion of the production area and installation of equipment in Building 3 at the Konosu Research Institute, as well as increases in inventories of new products and intermediate inventories for overseas products.」
The expansion of the production area and installation of equipment in Building 3 at the Konosu Research Institute continued, resulting in an increase in property, plant and equipment. Investing activities included the acquisition of ¥1,473 million in property, plant and equipment related to the institute. - FY2020-Q1AdvancedAnnual report
「Cash used in investing activities amounted to ¥464 million, compared with ¥325 million used in the same period of the previous year. This was mainly attributable to the acquisition of ¥432 million in property, plant and equipment associated with the installation of equipment and other activities at the Konosu Research Institute.」
The installation of equipment at the Konosu Research Institute continued, and the acquisition of ¥432 million in property, plant and equipment was recorded. - FY2019AdvancedAnnual report
「Cash used in investing activities amounted to ¥1,895 million, compared with ¥5,312 million used in the same period of the previous year. This was mainly attributable to the acquisition of ¥1,513 million in property, plant and equipment associated with the installation of new equipment and other activities at the Konosu Research Institute.」
The installation of new equipment at the Konosu Research Institute continued after completion of Building 3, and the acquisition of ¥1,513 million in property, plant and equipment was recorded. - FY2019-Q3AdvancedAnnual report
「This was mainly due to the acquisition of ¥1,189 million in property, plant and equipment associated with the installation of new equipment at the Konosu Research Institute.」
Following the expansion of production equipment related to Building 3, the installation of new equipment at the Konosu Research Institute also progressed during the cumulative third-quarter period. - FY2019-Q2AdvancedAnnual report
「This was mainly attributable to the acquisition of ¥782 million in property, plant and equipment associated with the installation of new equipment and other activities at the Konosu Research Institute.」
The acquisition of ¥782 million in property, plant and equipment associated with the installation of new equipment and other activities at the Konosu Research Institute was recorded. - FY2019-Q1AdvancedAnnual report
「This was mainly due to the acquisition of ¥428 million in property, plant and equipment in connection with the opening of childcare facilities and the installation of equipment at the Konosu Research Institute.」
Equipment installation at the Konosu Research Institute continued after completion of Building 3, with the acquisition of ¥428 million in property, plant and equipment recorded. - FY2018-Q3AdvancedAnnual report
「The main factor was a ¥2,634 million increase in property, plant and equipment, from ¥15,853 million to ¥18,487 million, following completion of Building 3 at the Konosu Research Institute and in preparation for the opening of a childcare facility.」
Building 3 at the Konosu Research Institute was completed, and property, plant and equipment, including the installation of equipment, increased by ¥2,634 million, from ¥15,853 million to ¥18,487 million. - FY2018-Q2AdvancedAnnual report
「The main factors included the acquisition of land for the opening of a childcare facility and construction of Building 3, which resulted in a ¥2,425 million increase in property, plant and equipment, from ¥15,853 million to ¥18,279 million.」
Construction of Building 3 at the Konosu Research Institute progressed, and property, plant and equipment increased by ¥2,425 million, from ¥15,853 million to ¥18,279 million. - FY2018-Q1AdvancedAnnual report
「Property, plant and equipment increased by ¥666 million, from ¥15,853 million to ¥16,520 million, due to an increase in construction in progress associated with construction of Building 3 at the Konosu Research Institute.」
Construction of Building 3 at the Konosu Research Institute progressed, and property, plant and equipment increased by ¥666 million, including the increase in construction in progress. - FY2017-Q3AdvancedAnnual report
「The main factors included a ¥2,152 million increase in property, plant and equipment, from ¥13,752 million to ¥15,904 million, following completion of the research building and partial expansion of the manufacturing equipment in Building 2.」
In addition to completion of the research building, part of the manufacturing equipment in Building 2 was expanded, increasing property, plant and equipment from ¥13,752 million to ¥15,904 million. - FY2017-Q1AdvancedAnnual report
「The main factor was a ¥1,023 million increase in property, plant and equipment, from ¥13,752 million to ¥14,776 million, following completion of the research building.」
Completion of the research building was reported, with property, plant and equipment increasing by ¥1,023 million. This represented concrete construction progress toward expanding production capacity and capabilities for new materials through the new building. - FY2016First statedAnnual report
「At a meeting of the Board of Directors held on 13 June 2016, we resolved to acquire fixed assets, namely, to construct a new building at the Konosu Research Institute, for the purpose of increasing production capacity and accommodating the manufacture of contact lenses using new materials.」
For Building 3 of the new facility, the planned total investment was approximately ¥5.2 billion, with construction scheduled to begin in November 2016 and completion scheduled for September 2017. Planned production capacity was approximately 1,000 sheets per month. The facilities plan stated that capacity after completion of the disposable-lens manufacturing equipment would increase by approximately 30%.